Among individuals in Sweden receiving second-generation drug-eluting stents, those with diabetes, particularly type 1 diabetes, have higher rates of stent failure than those without diabetes. Medscape News UK
We scan the top radiology sources so you don’t have to.
From AI breakthroughs to imaging trends, we serve up real-time radiology insights.
-
Benefits of Structured Lifestyle Program in US POINTER Trial
Beyond cognition, structured lifestyle delivers may also improve sleep apnea, blood pressure regulation and cognitive resilience, new data from US POINTER trial shows. Medscape Medical News
-
Does Treatment Timing Affect Chemoradiation Response?
Dr Maurie Markman discusses a recent study from Memorial Sloan Kettering investigating time of day and its effect on chemoradiotherapy and checkpoint inhibitor therapy. Medscape Oncology
-
AI Imaging Halves Delays in Stroke Patient Transfers
A study shows AI imaging software can significantly speed NHS stroke care, cutting delays and increasing thrombectomy rates. Medscape News UK
-
When RVUs Go Wrong: Red Flags for Physicians
Many physicians aren’t as familiar with RVUs as they’d like to be. Here’s some advice about RVUs in employment contracts from an experienced attorney who represents physicians. Medscape Medical News
-
A Cryptic Case: When You Don’t Know What You Don’t Know
A cardiologist sees a patient in the ICU with apparent anaphylaxis. She reassures him that his heart is fine but later learned the surprising diagnosis with long-term cardiovascular implications. theheart.org on Medscape
-
AI Could Ease Caregiver Burden for Older Adults, Study Finds
Experts say many AI tools intend to support older adults, but trust, cost, and design gaps could slow adoption. Medscape Medical News
-
How Often Do Contrast Media Reactions Turn Severe?
Although anaphylactic reactions to iodinated contrast media used in CT imaging are rare, a substantial proportion of these reactions are life threatening, a decade-long study finds. Medscape Medical News
-
Expanding Immunotherapy in Early-Stage HR+ and TNBC
Dr Hope Rugo explores how new data suggest immunotherapy could reshape the standard of care for early-stage HR+ and triple-negative breast cancers. Medscape Oncology
-
First-Line Decisions in Metastatic Pancreatic Cancer
In this installment of Case-by-Case, Dr Emil Lou guides clinicians through choosing between frontline regimens for metastatic pancreatic cancer. Medscape Oncology